2021 Q3 Form 10-Q Financial Statement

#000114036121037683 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.616M $942.5K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.616M $942.5K
YoY Change
Operating Profit -$1.616M -$942.5K
YoY Change
Interest Expense $7.250K $1.890K
YoY Change
% of Operating Profit
Other Income/Expense, Net $6.561M $2.573M
YoY Change
Pretax Income $4.953M $1.631M
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $4.953M $1.631M
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $137.8K $45.37K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $379.3K $871.5K
YoY Change
Cash & Equivalents $379.3K $871.5K
Short-Term Investments
Other Short-Term Assets $701.3K $1.021M
YoY Change
Inventory
Prepaid Expenses $1.021M
Receivables
Other Receivables
Total Short-Term Assets $1.081M $1.892M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $287.5M $287.5M
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $287.5M $287.5M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.081M $1.892M
Total Long-Term Assets $287.5M $287.5M
Total Assets $288.6M $289.4M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.386M $126.9K
YoY Change
Accrued Expenses $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.386M $126.9K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $22.96M $28.16M
YoY Change
Total Long-Term Liabilities $22.96M $28.16M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.386M $126.9K
Total Long-Term Liabilities $22.96M $28.16M
Total Liabilities $24.34M $28.29M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$28.79M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $264.3M -$26.40M
YoY Change
Total Liabilities & Shareholders Equity $288.6M $289.4M
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q1
OPERATING ACTIVITIES
Net Income $4.953M $1.631M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$194.4K -$1.078M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$287.5M
YoY Change
Cash From Investing Activities $0.00 -$287.5M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 289.4M
YoY Change
NET CHANGE
Cash From Operating Activities -194.4K -1.078M
Cash From Investing Activities 0.000 -287.5M
Cash From Financing Activities 0.000 289.4M
Net Change In Cash -194.4K 849.6K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$194.4K -$1.078M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001835972
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1615840
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
28750000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3013121
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
28276
CY2021Q1 arrw Redeemable Ordinary Shares Accretion To Redemption Value
RedeemableOrdinarySharesAccretionToRedemptionValue
-28713942
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1630620
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-26395046
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1805013
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-28200059
arrw Deferred Underwriting Fee Charged
DeferredUnderwritingFeeCharged
10062500
CY2021Q3 us-gaap Cash
Cash
379336
CY2021Q3 arrw Working Capital
WorkingCapital
287516386
us-gaap Investment Income Interest
InvestmentIncomeInterest
16386
CY2021Q3 arrw Net Tangible Assets Threshold For Redeeming Public Shares
NetTangibleAssetsThresholdForRedeemingPublicShares
5000001
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
287500000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28786407
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-28785688
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><span style="font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Concentration of Credit Risk</span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</div>
arrw Threshold Consecutive Trading Days
ThresholdConsecutiveTradingDays
P30D
arrw Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
arrw Period To Exercise Warrants After Closing Of Initial Public Offering
PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering
P12M
CY2021Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
arrw Period To File Registration Statement After Initial Business Combination
PeriodToFileRegistrationStatementAfterInitialBusinessCombination
P15D
arrw Period For Registration Statement To Become Effective
PeriodForRegistrationStatementToBecomeEffective
P60D
CY2021Q3 arrw Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.01
arrw Notice Period To Redeem Warrants
NoticePeriodToRedeemWarrants
P30D
arrw Threshold Trading Days
ThresholdTradingDays
P20D
CY2021Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0

Files In Submission

Name View Source Status
0001140361-21-037683-index-headers.html Edgar Link pending
0001140361-21-037683-index.html Edgar Link pending
0001140361-21-037683.txt Edgar Link pending
0001140361-21-037683-xbrl.zip Edgar Link pending
arrw-20210930.xsd Edgar Link pending
arrw-20210930_cal.xml Edgar Link unprocessable
arrw-20210930_def.xml Edgar Link unprocessable
arrw-20210930_lab.xml Edgar Link unprocessable
arrw-20210930_pre.xml Edgar Link unprocessable
brhc10030450_10q.htm Edgar Link pending
brhc10030450_10q_htm.xml Edgar Link completed
brhc10030450_ex31-1.htm Edgar Link pending
brhc10030450_ex31-2.htm Edgar Link pending
brhc10030450_ex32-1.htm Edgar Link pending
brhc10030450_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending